Zobrazeno 1 - 8
of 8
pro vyhledávání: '"F. E. Psarakis"'
Autor:
Anna Boula, George Tsirakis, Constantina A. Pappa, Ioannis K. Neonakis, Nektaria Goulidaki, F. E. Psarakis, Michael G. Alexandrakis
Publikováno v:
Pathology & Oncology Research. 21:929-934
In multiple myeloma the angiogenic process is enhanced by various mediators. Among them interleukin-10 (IL-10), secreted mainly by myeloma-associated macrophages seems to participate in myeloma progression with variable manners. The aim of the study
Autor:
Constantina A. Pappa, Anna Boula, E. Stavroulaki, George Tsirakis, V Bantouna, A. Kolovou, F. E. Psarakis, Michael G. Alexandrakis
Publikováno v:
Hematological Oncology. 31:201-205
Angiogenesis is an essential process for the expansion of multiple myeloma (MM), in which many angiogenic factors participate. Endoglin (CD105) is a transforming growth factor-β co-receptor, being mainly expressed in angiogenic endothelial cells and
Autor:
Constantina A. Pappa, M. Spanoudakis, Dimosthenis Chochlakis, Michael G. Alexandrakis, Efstathios N. Stathopoulos, M. Stratinaki, George Tsirakis, Athanasios Alegakis, F. E. Psarakis
Publikováno v:
European Journal of Internal Medicine. 23:368-373
Background Τhe importance of angiogenesis in malignancies' growth is well recognized. CD105 (Endoglin), a proliferation-associated glycoprotein, is a powerful marker of neovascularization. Elevated amounts of solubleCD105 (sCD105) have been identifi
Autor:
M. Fragioudaki, Constantina A. Pappa, George Tsirakis, Constantinos Tsioutis, Michael G. Alexandrakis, Anna Boula, F. E. Psarakis, E. Stavroulaki
Publikováno v:
Medical Oncology. 29:2396-2401
Multiple myeloma (MM) is a disease of plasma cells that express the CD40 receptor. Binding of the CD40 by its natural ligand, CD40 ligand (CD40L), produces growth arrest and/or apoptosis in MM. To evaluate serum levels of soluble CD40L (sCD40L) in MM
Autor:
Constantina A. Pappa, Maria A. Stratinaki, George Tsirakis, Athina Xekalou, George Sakellaris, Efstathios N. Stathopoulos, F. E. Psarakis, Athanasios Alegakis, Peggy Kanellou, Michael G. Alexandrakis
Publikováno v:
Hematological Oncology. 30:131-136
Angiogenesis is a complex process essential for the growth, invasion, and metastasis of various malignant tumours, including multiple myeloma (MM). Various angiogenic cytokines have been implicated in the angiogenic process. Among them, platelet-deri
Autor:
F. E. Psarakis, D. Stafylaki, Michael G. Alexandrakis, Constantina A. Pappa, K. Sfiridaki, George Tsirakis, Anna Kolovou, M. Tsigaridaki
Publikováno v:
Medical Oncology. 30
There are many growth factors influencing the expansion of multiple myeloma (MM). Angiogenesis is a process that may enhance MM growth, in various manners. Among them, insulin-like growth factor-1 (IGF-1) is a major factor, acting in many levels. The
Autor:
C A, Pappa, M G, Alexandrakis, A, Boula, F E, Psarakis, A, Kolovou, V, Bantouna, E, Stavroulaki, G, Tsirakis
Publikováno v:
Hematological oncology. 31(4)
Angiogenesis is an essential process for the expansion of multiple myeloma (MM), in which many angiogenic factors participate. Endoglin (CD105) is a transforming growth factor-β co-receptor, being mainly expressed in angiogenic endothelial cells and
Autor:
M. Spanoudakis, Michael G. Alexandrakis, George Tsirakis, I. S. Papadakis, F. E. Psarakis, Anna Boula, Constantina A. Pappa, M. Fragioudaki
Publikováno v:
Annals of hematology. 91(9)
B cell-activating factor (BAFF) is a cytokine that plays a major role in the maintenance of normal B-cell development and homeostasis. It has been suggested that in multiple myeloma (MM) it might have regulatory effects on the proliferation and viabi